The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma ...
A Brazilian study involving nearly 900 participants under the age of 40 reinforces the idea that premature lung aging is ...
Strict control of comorbidities in patients with chronic obstructive pulmonary disease decreases exacerbations, morbimortality, and avoids readmissions. An increasing number of women have the disease, ...
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) congratulates UN Member States for recognizing that chronic obstructive pulmonary disease(COPD) is a major cause of disability and ...
GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterised by persistent airflow limitation and chronic inflammation. Beyond its primary pulmonary manifestations, ...
Using coronary artery calcium scores alongside cardiovascular risk scores better identifies patients with chronic obstructive ...
India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...
The UCR accepts referrals from GPs, Hampshire hospitals, ambulance services, families, and patients themselves. It helps ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback